More and more scientists are taking advantage of DNA microarray chip technology to further their research. PubMed can give a rough estimate of the growth and acceptance of this technology; a search ...

U.S. Protein Chip Market was valued at USD 0.96 billion in 2025 and is expected to reach USD 1.87 billion by 2035 due to world-class academic and research infrastructureAustin, April 01, 2026 (GLOBE ...

Alongside the rebrand, Terrestrial is planning to establish a new headquarters and manufacturing facility in Boston.

The Australian Medtech Manufacturing Alliance highlights how three local manufacturers are winning through automation.

Micron Biomedical will be among the select honorees featured in the print edition of Fast Company on newsstands beginning March 31, 2026.

Abnormal expression of microRNAs (miRNAs) in cancer suggests their applicability as diagnostic and prognostic signatures. Here we describe a new microarray platform, miRCURY™ LNA, based on Locked ...

A protein microarray consists of the immobilization of proteins in organized rows and columns upon a support structure. The structure of the protein microarray allows for high-throughput analysis of ...

LuxScan 10K Microarray Scanner is a compact high performance system for microarray imaging and data analysis of DNA, protein and cell arrays. Its advanced systems for optics, signal processing and ...

A large meta-analysis of over 20,000 people found that modern genetic testing can identify a clinically meaningful cause of schizoprenia in about 1 in 16 patients (6%), especially in early-onset ...

Tirupati: Withr are diseases often going undiagnosed due to lack of awareness, the Department of Paediatrics at Sri ...

Terrestrial Bio, a Woburn-based therapeutics company, announced last week that it would lease a new manufacturing facility in ...

This year’s most innovative smaller companies prove that head count doesn’t cap ambition. These Small and Mighty standouts (51 to 200 employees) are thinking well beyond their ...